Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Indexing Information

Abstracted and Indexed in:

  • BIOBASE
  • Biochemistry & Biophysics Citation Index®
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • Biotechnology Citation Index®
  • British Library
  • Cambridge Scientific Abstracts (CSA)/ProQuest
  • Chemical Abstracts Service/SciFinder
  • ChemWeb
  • CNKI Scholar
  • Dimensions
  • EBSCO
  • EMBASE
  • ERA 2018
  • Genamics JournalSeek
  • Google Scholar
  • InCites
  • Index Copernicus
  • Index to Scientific Reviews®
  • ISI Alerting Service
  • J-Gate
  • Journal Citation Reports/Science Edition
  • JournalTOCs
  • MediaFinder®-Standard Periodical Directory
  • MEDLINE/PubMed/Index Medicus
  • Norwegian Register
  • Open Abstracts (I4OA)
  • Prous Science Integrity
  • PubsHub
  • QOAM
  • Science Citation Index Expanded™ (SciSearch®)
  • Scilit
  • Scopus
  • Suweco CZ
  • TOC Premier
  • Ulrich's Periodicals Directory


Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Mechanisms-of-Metabolic-Disorders-(MMD)

Related Journals

Related eBooks

eBooks Catalog